⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL416374 | 0.80 | — | — | |
| SCHEMBL113475 | 0.80 | — | — | |
| SCHEMBL29614877 | 0.78 | — | — | |
| SCHEMBL1013212 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL7423355 | 0.77 | CES2 (0.39) | — | |
| Methane SCHEMBL1703075 | 0.77 | SMN1; SMN2 (0.43) | — | |
| Bromide SCHEMBL29216576 | 0.77 | CES2 (0.39) | — | |
| Iodide SCHEMBL29216564 | 0.77 | CES2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL3490277 | 0.76 | CD44 (0.46) | — | |
| SCHEMBL31414602 | 0.76 | CA1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 425 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528741-A | Preparation method of rituximab key intermediate | 济南鼎皓医药科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119529469-A | High-frequency high-speed phenolic resin-based copper-clad plate and preparation method thereof | 江苏耀鸿电子有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-116063184-B | Preparation method of 2-bromo-6-fluoroaniline | 浙江车头制药股份有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-118702633-A | Preparation method of drug chlorinated intermediate for preventing cytomegalovirus infection | 台州职业技术学院 | 2024-09-27 | — | — | CN | claimed |
| CN-118084678-B | Preparation method of 2-bromo-6-fluoroaniline | 长沙唯楚医药科技有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-118373778-A | Preparation method of letromycin | 湖北广济医药科技有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-118084678-A | Preparation method of 2-bromo-6-fluoroaniline | 长沙唯楚医药科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-114539085-B | Preparation of ureido derivatives | 山东诚创蓝海医药科技有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116874436-A | Preparation method of letromycin intermediate | 济宁学院 | 2023-10-13 | — | — | CN | claimed |
| CN-116063184-A | Preparation method of 2-bromo-6-fluoroaniline | 浙江车头制药股份有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-115784896-A | Preparation method of 2-bromo-6-fluoroaniline | 山东诚创蓝海医药科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-114539085-A | Preparation of ureido derivative | 山东诚创蓝海医药科技有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-101374799-B | Process for preparing substituted biphenyls | BASF SE | 2012-05-23 | — | — | CN | claimed |
| US-7709684-B2 | Process for preparing substituted biphenyls | BASF SE (DE) | 2010-05-04 | — | — | US | claimed |
| EP-2029519-A1 | PROCESS FOR PREPARING SUBSTITUTED BIPHENYLS | BASF SE (DE) | 2009-03-04 | — | — | EP | claimed |
| CN-101374799-A | Process for preparing substituted biphenyls | BASF SE (DE) | 2009-02-25 | — | — | CN | claimed |
| US-20090005597-A1 | Process for Preparing Substituted Biphenyls | BASF SE (DE) | 2009-01-01 | — | — | US | claimed |
| WO-2007138089-A1 | PROCESS FOR PREPARING SUBSTITUTED BIPHENYLS | BASF SE (DE) | 2007-12-06 | — | — | WO | claimed |
| WO-2007117482-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | claimed |
| WO-2026106929-A1 | DIHYDROQUINAZOLINES USEFUL AS CYTOMEGALOVIRUS ANTIVIRAL AGENTS | ASSEMBLY BIOSCIENCES, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12630566-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20250381187-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC. (US) | 2025-12-18 | — | — | US | disclosed |
| WO-2025229495-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-11-06 | — | — | WO | disclosed |
| WO-2025229494-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-11-06 | — | — | WO | disclosed |
| US-12440491-B2 | KRAS G12C inhibitors and methods of using the same | AMGEN INC. (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250304537-A1 | HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | REPARE THERAPEUTICS INC. (CA) | 2025-10-02 | — | — | US | disclosed |
| CN-116874436-B | Leitemivir Process for the preparation of intermediates | 济宁学院 | 2025-08-08 | — | — | CN | disclosed |
| US-12331026-B2 | Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors | NIKANG THERAPEUTICS, INC. (US) | 2025-06-17 | — | — | US | disclosed |
| US-20250188046-A1 | ULTRAFAST FLOW SYNTHESIS OF FUNCTIONALIZED SULFONYL FLUORIDES AND SUBSEQUENT SUFEX CONNECTIONS VIA LITHIATED CHEMISTRY | POSTECH Research and Business Development Foundation (KR) | 2025-06-12 | — | — | US | disclosed |
| WO-2025111184-A1 | SUBSTITUTED TETRAHYDROQUINOLINE AND TETRAHYDROQUINOXALINE HERBICIDES | FMC CORPORATION (US) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025108342-A1 | AROMATIC RING-FUSED THIAZINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | 杭州百诚医药科技股份有限公司 | 2025-05-30 | — | — | WO | disclosed |
| CN-120020131-A | Aromatic ring benzothiazine derivative and medical application thereof | 杭州百诚医药科技股份有限公司 | 2025-05-20 | — | — | CN | disclosed |
| CN-119894872-A | Heteroarenes, pharmaceutical compositions containing heteroarenes, and methods of use thereof | 修复治疗公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119798172-A | Preparation method of Leitemivir key intermediate dihydroquinazoline ester | 仁合益康集团有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-116102541-B | Compounds as NMT inhibitors and uses thereof | 石药集团中奇制药技术（石家庄）有限公司 | 2025-04-08 | — | — | CN | disclosed |
| EP-4526293-A1 | HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | Repare Therapeutics Inc. (CA) | 2025-03-26 | — | — | EP | disclosed |
| CN-119528741-A | Preparation method of rituximab key intermediate | 济南鼎皓医药科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119528741-A | Preparation method of rituximab key intermediate | 济南鼎皓医药科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119529469-A | High-frequency high-speed phenolic resin-based copper-clad plate and preparation method thereof | 江苏耀鸿电子有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119529469-A | High-frequency high-speed phenolic resin-based copper-clad plate and preparation method thereof | 江苏耀鸿电子有限公司 | 2025-02-28 | — | — | CN | disclosed |
| WO-2025038917-A1 | HETEROARYL AMINE COMPOUNDS AND USES THEREOF | XENON PHARMACEUTICALS INC. (CA) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025038920-A1 | HETEROARYL AMINE COMPOUNDS AND USES THEREOF | XENON PHARMACEUTICALS, INC. (CA) | 2025-02-20 | — | — | WO | disclosed |
| CN-116063184-B | Preparation method of 2-bromo-6-fluoroaniline | 浙江车头制药股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-116063184-B | Preparation method of 2-bromo-6-fluoroaniline | 浙江车头制药股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-116063184-B | Preparation method of 2-bromo-6-fluoroaniline | 浙江车头制药股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| EP-4472968-A1 | INHIBITORS OF RAF KINASES | PIERRE FABRE MEDICAMENT (FR) | 2024-12-11 | — | — | EP | disclosed |
| CN-119053595-A | Sulfonylamino derivatives as cyclin dependent kinase 2 inhibitors | 尼坎治疗公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-118974036-A | Inhibitors of RAF kinase | 皮埃尔法布雷医药公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118702633-A | Preparation method of drug chlorinated intermediate for preventing cytomegalovirus infection | 台州职业技术学院 | 2024-09-27 | — | — | CN | disclosed |
| US-20240309020-A1 | KRAS G12D INHIBITORS | ARRAY BIOPHARMA INC. | 2024-09-19 | — | — | US | disclosed |
| CN-118084678-B | Preparation method of 2-bromo-6-fluoroaniline | 长沙唯楚医药科技有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-118084678-B | Preparation method of 2-bromo-6-fluoroaniline | 长沙唯楚医药科技有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-118084678-B | Preparation method of 2-bromo-6-fluoroaniline | 长沙唯楚医药科技有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-118373778-A | Preparation method of letromycin | 湖北广济医药科技有限公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-118373778-A | Preparation method of letromycin | 湖北广济医药科技有限公司 | 2024-07-23 | — | — | CN | disclosed |
| US-20240208991-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD (KR) | 2024-06-27 | — | — | US | disclosed |
| US-20240208991-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD (KR) | 2024-06-27 | — | — | US | disclosed |
| CN-118184669-A | Macrocyclic compounds as multi-target kinase inhibitors | 北京伯汇生物技术有限公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20240182467-A1 | INHIBITORS OF RAF KINASES | Pierre Fabre Médicament (FR) | 2024-06-06 | — | — | US | disclosed |
| CN-118084807-A | Refining method of 3, 4-dihydro quinazoline compound | 南京正大天晴制药有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-118084678-A | Preparation method of 2-bromo-6-fluoroaniline | 长沙唯楚医药科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-118084678-A | Preparation method of 2-bromo-6-fluoroaniline | 长沙唯楚医药科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-118084678-A | Preparation method of 2-bromo-6-fluoroaniline | 长沙唯楚医药科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024099478-A1 | INHALABLE AROMATIC RING THIAZIDE AND ANALOG, PHARMACEUTICAL COMPOSITION CONTAINING INHALABLE AROMATIC RING THIAZINE, AND USE OF INHALABLE AROMATIC RING THIAZINE IN ANTI-INFLAMMATION AND ANTI-TUMOR | 杭州百诚医药科技股份有限公司 | 2024-05-16 | — | — | WO | disclosed |
| US-11964989-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2024-04-23 | — | — | US | disclosed |
| CN-114615981-B | KRAS G12D inhibitors | 米拉蒂治疗股份有限公司 | 2024-04-12 | — | — | CN | disclosed |
| US-20240109884-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2024-04-04 | — | — | US | disclosed |
| CN-117756836-A | Heteroaryl compound containing boron, nitrogen and silicon, organic electroluminescent device and display device | 阜阳欣奕华材料科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117658928-A | New preparation method of drug intermediate for preventing CMV infection | 北京康立生医药技术开发有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-20240050430-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC. | 2024-02-15 | — | — | US | disclosed |
| CN-117486808-A | Novel preparation method of letromycin key intermediate | 北京康立生医药技术开发有限公司 | 2024-02-02 | — | — | CN | disclosed |
| WO-2023231826-A1 | LETERMOVIR INTERMEDIATE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | 浙江车头制药股份有限公司 | 2023-12-07 | — | — | WO | disclosed |
| CN-115322157-B | Letermopevir intermediate compound, preparation method and application thereof | 浙江车头制药股份有限公司 | 2023-12-05 | — | — | CN | disclosed |
| WO-2023220831-A1 | HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | REPARE THERAPEUTICS INC. (CA) | 2023-11-23 | — | — | WO | disclosed |
| CN-117088867-A | Inhalable aromatic ring thiazide and analogue, pharmaceutical composition containing inhalable aromatic ring thiazide and analogue and application of inhalable aromatic ring thiazide and analogue in anti-inflammatory and anti-tumor | 杭州百诚医药科技股份有限公司 | 2023-11-21 | — | — | CN | disclosed |
| US-11814384-B2 | Inhibtors of Raf kinases | KINNATE BIOPHARMA INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814384-B2 | Inhibtors of Raf kinases | KINNATE BIOPHARMA INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814384-B2 | Inhibtors of Raf kinases | KINNATE BIOPHARMA INC. (US) | 2023-11-14 | — | — | US | disclosed |
| CN-116917292-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-10-20 | — | — | CN | disclosed |
| CN-114539085-B | Preparation of ureido derivatives | 山东诚创蓝海医药科技有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-RE49698-E1 | Substituted dihydroquinazolines | AIC246 AG & CO. KG (DE) | 2023-10-17 | — | — | US | disclosed |
| US-RE49698-E1 | Substituted dihydroquinazolines | AIC246 AG & CO. KG (DE) | 2023-10-17 | — | — | US | disclosed |
| US-RE49698-E1 | Substituted dihydroquinazolines | AIC246 AG & CO. KG (DE) | 2023-10-17 | — | — | US | disclosed |
| CN-116874436-A | Preparation method of letromycin intermediate | 济宁学院 | 2023-10-13 | — | — | CN | disclosed |
| CN-116874436-A | Preparation method of letromycin intermediate | 济宁学院 | 2023-10-13 | — | — | CN | disclosed |
| EP-3788038-B1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-3788038-B1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC (US) | 2023-10-11 | — | — | EP | disclosed |
| WO-2023192801-A1 | SULFONAMIDO DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS | NIKANG THERAPEUTICS, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| US-20230303509-A1 | SULFONAMIDO DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS | NIKANG THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |
| US-20230303509-A1 | SULFONAMIDO DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS | NIKANG THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |
| US-20230303509-A1 | SULFONAMIDO DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS | NIKANG THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |
| US-20230303566-A1 | INHIBITORS OF RAF KINASES | Pierre Fabre Médicament (FR) | 2023-09-28 | — | — | US | disclosed |
| US-20230303566-A1 | INHIBITORS OF RAF KINASES | Pierre Fabre Médicament (FR) | 2023-09-28 | — | — | US | disclosed |
| US-11766436-B2 | KRAS G12C inhibitors and methods of using the same | AMGEN INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-11766436-B2 | KRAS G12C inhibitors and methods of using the same | AMGEN INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-11766436-B2 | KRAS G12C inhibitors and methods of using the same | AMGEN INC. (US) | 2023-09-26 | — | — | US | disclosed |
| CN-116745302-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-09-12 | — | — | CN | disclosed |
| US-20230279025-A1 | KRAS G12D INHIBITORS | ARRAY BIOPHARMA INC. | 2023-09-07 | — | — | US | disclosed |
| US-20230279025-A1 | KRAS G12D INHIBITORS | ARRAY BIOPHARMA INC. | 2023-09-07 | — | — | US | disclosed |
| WO-2023150681-A1 | INHIBITORS OF RAF KINASES | KINNATE BIOPHARMA INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| WO-2023150681-A1 | INHIBITORS OF RAF KINASES | KINNATE BIOPHARMA INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| WO-2023116587-A1 | BINUCLEAR PLATINUM COMPLEX LUMINESCENT MATERIAL AND APPLICATION THEREOF | 广东阿格蕾雅光电材料有限公司 | 2023-06-29 | — | — | WO | disclosed |
| CN-113880776-B | Preparation method of rituximab intermediate | 山东诚创蓝海医药科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| CN-114174283-B | Compounds as NMT inhibitors and uses thereof | 石药集团中奇制药技术（石家庄）有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-116102541-A | Compounds as NMT inhibitors and uses thereof | 石药集团中奇制药技术（石家庄）有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-116063184-A | Preparation method of 2-bromo-6-fluoroaniline | 浙江车头制药股份有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-116063184-A | Preparation method of 2-bromo-6-fluoroaniline | 浙江车头制药股份有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-116063184-A | Preparation method of 2-bromo-6-fluoroaniline | 浙江车头制药股份有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-115850192-A | Process for preparing 3,4-dihydroquinazoline derivatives | 南京正大天晴制药有限公司 | 2023-03-28 | — | — | CN | disclosed |
| WO-2023039662-A1 | PHENANTHRIDINIUM DERIVATIVES AS PPM1A INHIBITORS AND USES THEREOF | UNIVERSITY OF OTTAWA (CA) | 2023-03-23 | — | — | WO | disclosed |
| CN-115784896-A | Preparation method of 2-bromo-6-fluoroaniline | 山东诚创蓝海医药科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115784896-A | Preparation method of 2-bromo-6-fluoroaniline | 山东诚创蓝海医药科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115784896-A | Preparation method of 2-bromo-6-fluoroaniline | 山东诚创蓝海医药科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| US-20230077225-A1 | KRAS G12D INHIBITORS | Mirati Therapeutics, Inc. | 2023-03-09 | — | — | US | disclosed |
| WO-2023012711-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-02-09 | — | — | WO | disclosed |
| WO-2023012711-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-02-09 | — | — | WO | disclosed |
| US-20220395504-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC. | 2022-12-15 | — | — | US | disclosed |
| CN-115322157-A | Letemovir intermediate compound and preparation method and application thereof | 浙江车头制药股份有限公司 | 2022-11-11 | — | — | CN | disclosed |
| WO-2022211500-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2022-10-06 | — | — | WO | disclosed |
| CN-114031560-B | Preparation method of letermovir sodium salt | 山东诚创蓝海医药科技有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-11453683-B1 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2022-09-27 | — | — | US | disclosed |
| CN-115010670-A | Chlorination method of Letemovir intermediate | 山东诚创蓝海医药科技有限公司 | 2022-09-06 | — | — | CN | disclosed |
| EP-4021444-A1 | KRAS G12D INHIBITORS | Mirati Therapeutics, Inc. (US) | 2022-07-06 | — | — | EP | disclosed |
| CN-114615981-A | KRAS G12D inhibitors | 米拉蒂治疗股份有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-114539085-A | Preparation of ureido derivative | 山东诚创蓝海医药科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114437074-A | Compound, pharmaceutical composition containing compound and application of compound | 北京伯汇生物技术有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-114174283-A | Compounds as NMT inhibitors and uses thereof | 石药集团中奇制药技术（石家庄）有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-114031560-A | Preparation method of letermovir sodium salt | 山东诚创蓝海医药科技有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-113880776-A | Preparation method of Latemozu intermediate | 山东诚创蓝海医药科技有限公司 | 2022-01-04 | — | — | CN | disclosed |
| US-11090304-B2 | KRAS G12C inhibitors and methods of using the same | AMGEN INC. (US) | 2021-08-17 | — | — | US | disclosed |
| WO-2021145401-A1 | SPIROHETEROCYCLIC DERIVATIVES AS CRHR2 ANTAGONIST | RAQUALIA PHARMA INC. (JP) | 2021-07-22 | — | — | WO | disclosed |
| EP-3788038-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | Amgen Inc. (US) | 2021-03-10 | — | — | EP | disclosed |
| WO-2021041671-A1 | KRAS G12D INHIBITORS | Mirati Therapeutics, Inc. (US) | 2021-03-04 | — | — | WO | disclosed |
| WO-2021041671-A1 | KRAS G12D INHIBITORS | Mirati Therapeutics, Inc. (US) | 2021-03-04 | — | — | WO | disclosed |
| CN-107001278-B | Tetrahydroisoquinoline derivatives | UCB生物制药私人有限公司 | 2020-11-24 | — | — | CN | disclosed |
| EP-3204359-B1 | TETRAHYDROISOQUINOLINE DERIVATIVES | UCB Biopharma SRL (BE) | 2020-07-01 | — | — | EP | disclosed |
| EP-2970186-B1 | 4-AMINO-6-(HETEROCYCLIC)PICOLINATES AND 6-AMINO-2-(HETEROCYCLIC) PYRIMIDINE-4-CARBOXYLATES AND THEIR USE AS HERBICIDES | DOW AGROSCIENCES LLC (US) | 2020-06-10 | — | — | EP | disclosed |
| US-20190343838-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC. | 2019-11-14 | — | — | US | disclosed |
| US-10189863-B2 | 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives | PULMOCIDE LIMITED (GB) | 2019-01-29 | — | — | US | disclosed |
| EP-2651981-B2 | ACTIVATING SUPPORTS | INEOS EUROPE AG (CH) | 2019-01-23 | — | — | EP | disclosed |
| WO-2019011228-A1 | IMIDAZO[1,2-B]PYRIMIDO[4,5-D]PYRIDAZIN-5(6H)-ONE COMPOUND AND USE THEREOF | 上海瑛派药业有限公司 | 2019-01-17 | — | — | WO | disclosed |
| EP-3204388-B1 | NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES | PULMOCIDE LTD (GB) | 2018-12-12 | — | — | EP | disclosed |
| EP-3165530-B1 | SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE | QILU PHARMACEUTICAL CO LTD (CN) | 2018-12-05 | — | — | EP | disclosed |
| US-10105359-B2 | Tetrahydroisoquinoline derivatives | UCB BIOPHARMA SPRL (BE) | 2018-10-23 | — | — | US | disclosed |
| US-10053477-B2 | Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide | QILU PHARMACEUTICAL CO., LTD. (CN) | 2018-08-21 | — | — | US | disclosed |
| EP-3113618-B1 | HETEROCYCLIC COMPOUNDS AS PEST CONTROLLERS | BAYER CROPSCIENCE AG (DE) | 2018-07-04 | — | — | EP | disclosed |
| EP-1622880-B3 | SUBSTITUTED DIHYDROCHINAZOLINES HAVING ANTIVIRAL PROPERTIES | AICURIS ANTI INFECTIVE CURES GMBH (DE) | 2018-05-23 | — | — | EP | disclosed |
| EP-1622880-B3 | SUBSTITUTED DIHYDROCHINAZOLINES HAVING ANTIVIRAL PROPERTIES | AICURIS ANTI INFECTIVE CURES GMBH (DE) | 2018-05-23 | — | — | EP | disclosed |
| US-20180127423-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBVIE DEUTSCHLAND (DE) | 2018-05-10 | — | — | US | disclosed |
| EP-2791189-B1 | NOVEL POLYMERS | INEOS EUROPE AG (CH) | 2018-05-02 | — | — | EP | disclosed |
| US-20180105509-A1 | AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS | ALMIRALL, S.A. (ES) | 2018-04-19 | — | — | US | disclosed |
| US-RE46791-E1 | Substituted dihydroquinazolines | AICURIS ANTI-INFECTIVE CURES GMBH (DE) | 2018-04-17 | — | — | US | disclosed |
| US-RE46791-E1 | Substituted dihydroquinazolines | AICURIS ANTI-INFECTIVE CURES GMBH (DE) | 2018-04-17 | — | — | US | disclosed |
| US-9920017-B2 | Heterocyclic compounds as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-20 | — | — | US | disclosed |
| US-9920017-B2 | Heterocyclic compounds as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-20 | — | — | US | disclosed |
| EP-3286178-A1 | AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS | Almirall S.A. (ES) | 2018-02-28 | — | — | EP | disclosed |
| US-9890128-B2 | Process for making substituted quinazoline compounds | MERCK SHARP & DOHME CORP. (US) | 2018-02-13 | — | — | US | disclosed |
| US-9890128-B2 | Process for making substituted quinazoline compounds | MERCK SHARP & DOHME CORP. (US) | 2018-02-13 | — | — | US | disclosed |
| US-20170355717-A1 | NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES | PULMOCIDE LIMITED (GB) | 2017-12-14 | — | — | US | disclosed |
| US-20170355717-A1 | NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES | PULMOCIDE LIMITED (GB) | 2017-12-14 | — | — | US | disclosed |
| US-20170355717-A1 | NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES | PULMOCIDE LIMITED (GB) | 2017-12-14 | — | — | US | disclosed |
| US-20170304292-A1 | Tetrahydroisoquinoline Derivatives | UCB BIOPHARMA SPRL (BE) | 2017-10-26 | — | — | US | disclosed |
| EP-3204359-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | UCB Biopharma SPRL (BE) | 2017-08-16 | — | — | EP | disclosed |
| EP-3204388-A1 | NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES | Pulmocide Limited (GB) | 2017-08-16 | — | — | EP | disclosed |
| US-9701679-B2 | Modulators of 5-HT receptors and methods of use thereof | Abb Vie Deutschland GmbH & Co. KG (DE) | 2017-07-11 | — | — | US | disclosed |
| US-20170129909-A1 | SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE | QUILU PHARMACEUTICAL CO., LTD. (CN) | 2017-05-11 | — | — | US | disclosed |
| EP-3165530-A1 | SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE | Qilu Pharmaceutical Co., Ltd (CN) | 2017-05-10 | — | — | EP | disclosed |
| EP-3150607-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | AbbVie Inc. (US) | 2017-04-05 | — | — | EP | disclosed |
| US-20170073318-A1 | HETEROCYCLIC COMPOUNDS AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-03-16 | — | — | US | disclosed |
| US-20170073318-A1 | HETEROCYCLIC COMPOUNDS AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-03-16 | — | — | US | disclosed |
| US-20170073318-A1 | HETEROCYCLIC COMPOUNDS AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-03-16 | — | — | US | disclosed |
| EP-2897938-B1 | FLUOROALKYL DIBENZODIAZEPINONE COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2017-03-15 | — | — | EP | disclosed |
| WO-2017012647-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | GALAPAGOS NV (BE) | 2017-01-26 | — | — | WO | disclosed |
| WO-2017012647-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | GALAPAGOS NV (BE) | 2017-01-26 | — | — | WO | disclosed |
| EP-3113618-A1 | HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS | Bayer CropScience Aktiengesellschaft (DE) | 2017-01-11 | — | — | EP | disclosed |
| EP-2490692-B1 | QUINOLINONE-PYRAZOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | MERCK SHARP & DOHME (US) | 2016-11-16 | — | — | EP | disclosed |
| EP-2560973-B1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBVIE INC (US) | 2016-11-16 | — | — | EP | disclosed |
| CN-104105722-B | Polymer | 英尼奥斯欧洲股份公司 | 2016-11-09 | — | — | CN | disclosed |
| WO-2016170009-A1 | AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS | ALMIRALL, S.A. (ES) | 2016-10-27 | — | — | WO | disclosed |
| US-20160311781-A1 | PROCESS FOR MAKING SUBSTITUTED QUINAZOLINE COMPOUNDS | MERCK SHARP & DOHME LLC | 2016-10-27 | — | — | US | disclosed |
| US-20160311781-A1 | PROCESS FOR MAKING SUBSTITUTED QUINAZOLINE COMPOUNDS | MERCK SHARP & DOHME LLC | 2016-10-27 | — | — | US | disclosed |
| US-20160311781-A1 | PROCESS FOR MAKING SUBSTITUTED QUINAZOLINE COMPOUNDS | MERCK SHARP & DOHME LLC | 2016-10-27 | — | — | US | disclosed |
| WO-2016109360-A1 | DIHYDROQUINAZOLINE INHIBITORS OF VIRAL TERMINASE | AUSPEX PHARMACEUTICALS, INC. (US) | 2016-07-07 | — | — | WO | disclosed |
| WO-2016109360-A1 | DIHYDROQUINAZOLINE INHIBITORS OF VIRAL TERMINASE | AUSPEX PHARMACEUTICALS, INC. (US) | 2016-07-07 | — | — | WO | disclosed |
| WO-2016055792-A1 | NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES | PULMOCIDE LIMITED (GB) | 2016-04-14 | — | — | WO | disclosed |
| WO-2016055792-A1 | NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES | PULMOCIDE LIMITED (GB) | 2016-04-14 | — | — | WO | disclosed |
| WO-2016055479-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | UCB BIOPHARMA SPRL (BE) | 2016-04-14 | — | — | WO | disclosed |
| EP-2651981-B1 | ACTIVATING SUPPORTS | INEOS EUROPE AG (CH) | 2016-03-16 | — | — | EP | disclosed |
| EP-2421870-B1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBVIE INC (US) | 2016-03-09 | — | — | EP | disclosed |
| EP-2970186-A1 | 4-AMINO-6-(HETEROCYCLIC)PICOLINATES AND 6-AMINO-2-(HETEROCYCLIC) PYRIMIDINE-4-CARBOXYLATES AND THEIR USE AS HERBICIDES | Dow AgroSciences LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2522671-B1 | Modulators of 5-HT receptors and methods of use thereof | ABBVIE INC (US) | 2016-01-20 | — | — | EP | disclosed |
| US-9175106-B2 | Activating supports | INEOS EUROPE AG (CH) | 2015-11-03 | — | — | US | disclosed |
| US-9175119-B2 | Polymers | INEOS EUROPE AG (CH) | 2015-11-03 | — | — | US | disclosed |
| US-9133126-B2 | Fluoroalkyl dibenzoazepinone compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-09-15 | — | — | US | disclosed |
| WO-2015132313-A1 | HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG (DE) | 2015-09-11 | — | — | WO | disclosed |
| WO-2015132313-A1 | HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG (DE) | 2015-09-11 | — | — | WO | disclosed |
| US-20150218104-A1 | FLUOROALKYL DIBENZOAZEPINONE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY | 2015-08-06 | — | — | US | disclosed |
| EP-2897938-A1 | FLUOROALKYL DIBENZODIAZEPINONE COMPOUNDS | Bristol-Myers Squibb Company (US) | 2015-07-29 | — | — | EP | disclosed |
| US-20150175611-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-06-25 | — | — | US | disclosed |
| WO-2015088931-A1 | PROCESS FOR MAKING SUBSTITUTED QUINAZOLINE COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2015-06-18 | — | — | WO | disclosed |
| WO-2015088931-A1 | PROCESS FOR MAKING SUBSTITUTED QUINAZOLINE COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2015-06-18 | — | — | WO | disclosed |
| US-9023864-B2 | Indole derivatives as CRTH2 receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2015-05-05 | — | — | US | disclosed |
| US-9023864-B2 | Indole derivatives as CRTH2 receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2015-05-05 | — | — | US | disclosed |
| US-9023864-B2 | Indole derivatives as CRTH2 receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2015-05-05 | — | — | US | disclosed |
| US-9006250-B2 | 4-amino-6-(heterocyclic)picolinates and 6-amino-2-(heterocyclic)pyrimidine-4-carboxylates and their use as herbicides | DOW AGROSCIENCES LLC (US) | 2015-04-14 | — | — | US | disclosed |
| EP-2492267-B1 | Indole derivatives as CRTH2 receptor antagonists in combination with a second active ingredient | MERCK SHARP & DOHME (US) | 2014-11-26 | — | — | EP | disclosed |
| EP-2492267-B1 | Indole derivatives as CRTH2 receptor antagonists in combination with a second active ingredient | MERCK SHARP & DOHME (US) | 2014-11-26 | — | — | EP | disclosed |
| US-8895580-B2 | Quinolinone-pyrazolone M1 receptor positive allosteric modulators | MERCK SHARP & DOHME CORP. (US) | 2014-11-25 | — | — | US | disclosed |
| US-20140329979-A1 | NOVEL POLYMERS | INEOS EUROPE AG (CH) | 2014-11-06 | — | — | US | disclosed |
| EP-2791189-A1 | NOVEL POLYMERS | Ineos Europe AG (CH) | 2014-10-22 | — | — | EP | disclosed |
| US-8846663-B2 | Modulators of 5-HT receptors and methods of use thereof | ABBVIE INC. (US) | 2014-09-30 | — | — | US | disclosed |
| WO-2014151009-A1 | 4-AMINO-6-(HETEROCYCLIC)PICOLINATES AND 6-AMINO-2-(HETEROCYCLIC) PYRIMIDINE-4-CARBOXYLATES AND THEIR USE AS HERBICIDES | DOW AGROSCIENCES LLC (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140274702-A1 | 4-AMINO-6-(HETEROCYCLIC)PICOLINATES AND 6-AMINO-2-(HETEROCYCLIC)PYRIMIDINE-4-CARBOXYLATES AND THEIR USE AS HERBICIDES | DOW AGROSCIENCES, LLC (US) | 2014-09-18 | — | — | US | disclosed |
| EP-2398324-B1 | PYRAZOLO [4,3-c]CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | MERCK SHARP & DOHME (US) | 2014-09-03 | — | — | EP | disclosed |
| US-8816075-B2 | Process for the preparation of dihydroquinazolines | AICURIS GMBH & CO. KG (DE) | 2014-08-26 | — | — | US | disclosed |
| US-8816075-B2 | Process for the preparation of dihydroquinazolines | AICURIS GMBH & CO. KG (DE) | 2014-08-26 | — | — | US | disclosed |
| US-8816075-B2 | Process for the preparation of dihydroquinazolines | AICURIS GMBH & CO. KG (DE) | 2014-08-26 | — | — | US | disclosed |
| US-8809365-B2 | 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders | UNIVERSITEIT GENT (BE) | 2014-08-19 | — | — | US | disclosed |
| WO-2014047370-A1 | FLUOROALKYL DIBENZODIAZEPINONE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-03-27 | — | — | WO | disclosed |
| US-8653079-B2 | Pyrazolo [4,3-C] cinnolin-3-one M1 receptor positive allosteric modulators | MERCK SHARP & DOHME CORP. (US) | 2014-02-18 | — | — | US | disclosed |
| EP-2401269-B1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2014-01-29 | — | — | EP | disclosed |
| US-20130310368-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBVIE INC. | 2013-11-21 | — | — | US | disclosed |
| EP-2651981-A2 | ACTIVATING SUPPORTS | Ineos Europe AG (CH) | 2013-10-23 | — | — | EP | disclosed |
| US-8546377-B2 | Modulators of 5-HT receptors and methods of use thereof | ABBVIE INC. (US) | 2013-10-01 | — | — | US | disclosed |
| CN-103328516-A | Activating supports | INEOS EUROPE AG | 2013-09-25 | — | — | CN | disclosed |
| US-8541406-B2 | Thiadiazole derivatives for the treatment of neurodegenerative diseases | NV REMYND (BE) | 2013-09-24 | — | — | US | disclosed |
| US-20130245214-A1 | ACTIVATING SUPPORTS | INEOS EUROPE AG (CH) | 2013-09-19 | — | — | US | disclosed |
| US-8518933-B2 | Modulators of 5-HT receptors and methods of use thereof | ABBVIE INC. (US) | 2013-08-27 | — | — | US | disclosed |
| US-8513255-B2 | Substituted dihydroquinazolines | AiCuris GmbH + Co. KG. (DE) | 2013-08-20 | — | — | US | disclosed |
| US-8513255-B2 | Substituted dihydroquinazolines | AiCuris GmbH + Co. KG. (DE) | 2013-08-20 | — | — | US | disclosed |
| US-8513255-B2 | Substituted dihydroquinazolines | AiCuris GmbH + Co. KG. (DE) | 2013-08-20 | — | — | US | disclosed |
| US-8486946-B2 | Pyrazolo [4,3-c] cinnolin-3-one M1 receptor positive allosteric modulators | MERCK SHARP & DOHME CORP. (US) | 2013-07-16 | — | — | US | disclosed |
| WO-2013087531-A1 | NOVEL POLYMERS | INEOS EUROPE AG (CH) | 2013-06-20 | — | — | WO | disclosed |
| US-20130150398-A1 | Indole Derivatives as CRTH2 Receptor Antagonists | MERCK SHARP & DOHME LLC | 2013-06-13 | — | — | US | disclosed |
| US-20130150398-A1 | Indole Derivatives as CRTH2 Receptor Antagonists | MERCK SHARP & DOHME LLC | 2013-06-13 | — | — | US | disclosed |
| US-20130150398-A1 | Indole Derivatives as CRTH2 Receptor Antagonists | MERCK SHARP & DOHME LLC | 2013-06-13 | — | — | US | disclosed |
| WO-2013056679-A1 | NOVEL HETEROARYL-AMINO DERIVATIVES | BEIJING HANMI PHARMACEUTICAL CO., LTD (CN) | 2013-04-25 | — | — | WO | disclosed |
| US-20130102599-A1 | PYRAZOLO [4,3-C] CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | MERCK SHARP & DOHME LLC | 2013-04-25 | — | — | US | disclosed |
| WO-2013056679-A1 | NOVEL HETEROARYL-AMINO DERIVATIVES | BEIJING HANMI PHARMACEUTICAL CO., LTD (CN) | 2013-04-25 | — | — | WO | disclosed |
| CN-101863843-B | Method for producing dihydroquinazolines | AICURIS GMBH & CO KG | 2013-03-27 | — | — | CN | disclosed |
| US-20130066073-A1 | PROCESS FOR THE PREPARATION OF DIHYDROQUINAZOLINES | AIC246 AG & CO. KG (DE) | 2013-03-14 | — | — | US | disclosed |
| US-20130066073-A1 | PROCESS FOR THE PREPARATION OF DIHYDROQUINAZOLINES | AIC246 AG & CO. KG (DE) | 2013-03-14 | — | — | US | disclosed |
| US-20130066073-A1 | PROCESS FOR THE PREPARATION OF DIHYDROQUINAZOLINES | AIC246 AG & CO. KG (DE) | 2013-03-14 | — | — | US | disclosed |
| US-8394819-B2 | Indole derivatives as CRTH2 receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2013-03-12 | — | — | US | disclosed |
| US-8394819-B2 | Indole derivatives as CRTH2 receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2013-03-12 | — | — | US | disclosed |
| US-8394819-B2 | Indole derivatives as CRTH2 receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2013-03-12 | — | — | US | disclosed |
| EP-2560973-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | Abbvie Inc. (US) | 2013-02-27 | — | — | EP | disclosed |
| US-8372972-B2 | Process for the preparation of dihydroquinazolines | AICURIS GMBH & CO. KG (DE) | 2013-02-12 | — | — | US | disclosed |
| US-8372972-B2 | Process for the preparation of dihydroquinazolines | AICURIS GMBH & CO. KG (DE) | 2013-02-12 | — | — | US | disclosed |
| US-8372972-B2 | Process for the preparation of dihydroquinazolines | AICURIS GMBH & CO. KG (DE) | 2013-02-12 | — | — | US | disclosed |
| US-8343981-B2 | Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents | AICURIS GMBH & CO. KG (DE) | 2013-01-01 | — | — | US | disclosed |
| US-8343981-B2 | Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents | AICURIS GMBH & CO. KG (DE) | 2013-01-01 | — | — | US | disclosed |
| US-8343981-B2 | Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents | AICURIS GMBH & CO. KG (DE) | 2013-01-01 | — | — | US | disclosed |
| WO-2012175991-A1 | FUSED PENTACYCLIC ANTI - PROLIFERATIVE COMPOUNDS | PHARMINOX LIMITED (GB) | 2012-12-27 | — | — | WO | disclosed |
| US-8314113-B2 | Substituted dihydroquinazolines II | AICURIS GMBH & CO. KG (DE) | 2012-11-20 | — | — | US | disclosed |
| US-8314113-B2 | Substituted dihydroquinazolines II | AICURIS GMBH & CO. KG (DE) | 2012-11-20 | — | — | US | disclosed |
| US-8314113-B2 | Substituted dihydroquinazolines II | AICURIS GMBH & CO. KG (DE) | 2012-11-20 | — | — | US | disclosed |
| EP-2522671-A2 | Modulators of 5-HT receptors and methods of use thereof | Abbott Laboratories (US) | 2012-11-14 | — | — | EP | disclosed |
| US-20120245196-A1 | 1-SUBSTITUTED 2-AZABICYCLO [3.1.1] HEPTYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS FOR TREATING NEUROLOGIC DISORDERS | UNIVERSITEIT GENT (BE) | 2012-09-27 | — | — | US | disclosed |
| EP-2496579-A1 | 1-SUBSTITUTED 2-AZABICYCLO [3.1.1]HEPTYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS FOR TREATING NEUROLOGIC DISORDERS | Universiteit Gent (BE) | 2012-09-12 | — | — | EP | disclosed |
| EP-2492267-A1 | Indole derivatives as CRTH2 receptor antagonists in combination with a second active ingredient | Merck Sharp & Dohme Corp. (US) | 2012-08-29 | — | — | EP | disclosed |
| EP-2492267-A1 | Indole derivatives as CRTH2 receptor antagonists in combination with a second active ingredient | Merck Sharp & Dohme Corp. (US) | 2012-08-29 | — | — | EP | disclosed |
| EP-2490692-A1 | QUINOLINONE-PYRAZOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | Merck Sharp & Dohme Corp. (US) | 2012-08-29 | — | — | EP | disclosed |
| US-20120196845-A1 | QUINOLINONE-PYRAZOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | MERCK SHARP & DOHME LLC | 2012-08-02 | — | — | US | disclosed |
| WO-2012080314-A2 | ACTIVATING SUPPORTS | INEOS EUROPE AG (CH) | 2012-06-21 | — | — | WO | disclosed |
| EP-2465876-A1 | Activating supports | INEOS Manufacturing Belgium NV (BE) | 2012-06-20 | — | — | EP | disclosed |
| CN-102482292-A | Modulators of 5-ht receptors and methods of use thereof | ABBOTT GMBH & CO KG | 2012-05-30 | — | — | CN | disclosed |
| US-20120130072-A1 | PROCESS FOR THE PREPARATION OF DIHYDROQUINAZOLINES | AICURIS GMBH & CO. KG (DE) | 2012-05-24 | — | — | US | disclosed |
| US-20120130072-A1 | PROCESS FOR THE PREPARATION OF DIHYDROQUINAZOLINES | AICURIS GMBH & CO. KG (DE) | 2012-05-24 | — | — | US | disclosed |
| US-20120130072-A1 | PROCESS FOR THE PREPARATION OF DIHYDROQUINAZOLINES | AICURIS GMBH & CO. KG (DE) | 2012-05-24 | — | — | US | disclosed |
| US-20120108533-A1 | NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) | 2012-05-03 | — | — | US | disclosed |
| EP-2424874-A1 | NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL ANGENTS | Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) | 2012-03-07 | — | — | EP | disclosed |
| EP-2421870-A2 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | Abbott Laboratories (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1893587-B1 | METHOD FOR PRODUCING DIHYDROQUINAZOLINES | AICURIS GMBH & CO KG (DE) | 2012-01-25 | — | — | EP | disclosed |
| CN-102333771-A | Indole derivatives as crth2 receptor antagonists | MERCK SHARP & DOHME | 2012-01-25 | — | — | CN | disclosed |
| EP-2401269-A1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2012-01-04 | — | — | EP | disclosed |
| EP-2398324-A1 | PYRAZOLO [4,3-c]CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | Merck Sharp & Dohme Corp. (US) | 2011-12-28 | — | — | EP | disclosed |
| US-8084604-B2 | Process for the preparation of dihydroquinazolines | Aicuris GmbH & Co., KG (DE) | 2011-12-27 | — | — | US | disclosed |
| US-8084604-B2 | Process for the preparation of dihydroquinazolines | Aicuris GmbH & Co., KG (DE) | 2011-12-27 | — | — | US | disclosed |
| US-8084604-B2 | Process for the preparation of dihydroquinazolines | Aicuris GmbH & Co., KG (DE) | 2011-12-27 | — | — | US | disclosed |
| US-20110301167-A1 | PYRAZOLO [4,3-c] CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | MERCK SHARP & DOHME LLC | 2011-12-08 | — | — | US | disclosed |
| WO-2011133182-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2011-10-27 | — | — | WO | disclosed |
| US-8017611-B2 | Pyridine and pyrazine derivatives -083 | ASTRAZENECA AB (SE) | 2011-09-13 | — | — | US | disclosed |
| EP-2215085-B1 | PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS | ASTRAZENECA AB (SE) | 2011-09-07 | — | — | EP | disclosed |
| CN-101213180-B | Process for preparing dihydroquinazolines | BAYER HEALTHCARE AG | 2011-09-07 | — | — | CN | disclosed |
| EP-1562913-B1 | SUBSTITUTED QUINAZOLINES AS ANTIVIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALOVIRUSES | AICURIS GMBH & CO KG (DE) | 2011-07-13 | — | — | EP | disclosed |
| EP-1562913-B1 | SUBSTITUTED QUINAZOLINES AS ANTIVIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALOVIRUSES | AICURIS GMBH & CO KG (DE) | 2011-07-13 | — | — | EP | disclosed |
| EP-2089394-B1 | SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES SRL (IT) | 2011-06-29 | — | — | EP | disclosed |
| US-20110130382-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2011-06-02 | — | — | US | disclosed |
| EP-2183260-B1 | PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV | IDENIX PHARMACEUTICALS INC (US) | 2011-06-01 | — | — | EP | disclosed |
| WO-2011054885-A1 | 1-SUBSTITUTED 2-AZABICYCLO [3.1.1] HEPTYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS FOR TREATING NEUROLOGIC DISORDERS | UNIVERSITEIT GENT (BE) | 2011-05-12 | — | — | WO | disclosed |
| WO-2011049731-A1 | QUINOLINONE-PYRAZOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | MERCK SHARP & DOHME CORP. (US) | 2011-04-28 | — | — | WO | disclosed |
| US-7932240-B2 | Phosphadiazine HCV polymerase inhibitors IV | IDENIX PHARMACEUTICALS, INC. (US) | 2011-04-26 | — | — | US | disclosed |
| EP-1490342-B1 | DISUBSTITUTED PYRAZOLYL CARBOXANILIDES | BAYER CROPSCIENCE AG (DE) | 2010-12-15 | — | — | EP | disclosed |
| CN-101910158-A | Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders | ASTRAZENECA AB | 2010-12-08 | — | — | CN | disclosed |
| US-7834007-B2 | CGRP antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-11-16 | — | — | US | disclosed |
| WO-2010125200-A1 | NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL ANGENTS | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) | 2010-11-04 | — | — | WO | disclosed |
| US-20100273767-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2010-10-28 | — | — | US | disclosed |
| WO-2010124042-A2 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2010-10-28 | — | — | WO | disclosed |
| CN-101863843-A | The method for preparing dihydroquinazoline | AICURIS GMBH & CO KG | 2010-10-20 | — | — | CN | disclosed |
| US-20100261707-A9 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | NV REMYND (BE) | 2010-10-14 | — | — | US | disclosed |
| CN-101842378-A | Phosphadiazine HCV polymerase inhibitors IV | IDENIX PHARMACEUTICALS INC (US) | 2010-09-22 | — | — | CN | disclosed |
| US-20100234415-A1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LLC | 2010-09-16 | — | — | US | disclosed |
| US-20100234415-A1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LLC | 2010-09-16 | — | — | US | disclosed |
| US-20100234415-A1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LLC | 2010-09-16 | — | — | US | disclosed |
| EP-2147915-B1 | New cycloalkylated benzothiadiazine derivatives, method of preparing same and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2010-09-15 | — | — | EP | disclosed |
| WO-2010099039-A1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010099039-A1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010096338-A1 | PYRAZOLO [4,3-c] CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | MERCK SHARP & DOHME CORP. (US) | 2010-08-26 | — | — | WO | disclosed |
| EP-2215085-A2 | PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS | AstraZeneca AB (SE) | 2010-08-11 | — | — | EP | disclosed |
| US-7772244-B2 | Therapeutic agents for the treatment of migraine | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-08-10 | — | — | US | disclosed |
| US-7741320-B2 | Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2010-06-22 | — | — | US | disclosed |
| US-7732463-B2 | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2010-06-08 | — | — | US | disclosed |
| EP-2183260-A1 | PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV | IDENIX Pharmaceuticals, Inc. (US) | 2010-05-12 | — | — | EP | disclosed |
| US-7709491-B2 | Substituted quinazolines as antiviral agents, especially against cytomegaloviruses | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-05-04 | — | — | US | disclosed |
| US-7709491-B2 | Substituted quinazolines as antiviral agents, especially against cytomegaloviruses | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-05-04 | — | — | US | disclosed |
| US-7709491-B2 | Substituted quinazolines as antiviral agents, especially against cytomegaloviruses | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-05-04 | — | — | US | disclosed |
| EP-2147915-A1 | New cycloalkylated benzothiadiazine derivatives, method of preparing same and pharmaceutical compositions containing them | Les Laboratoires Servier (FR) | 2010-01-27 | — | — | EP | disclosed |
| US-20100009974-A1 | Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them | LES LABORATOIRES SERVIER (FR) | 2010-01-14 | — | — | US | disclosed |
| WO-2010004139-A1 | NEW CYCLOALKYLATED BENZOTHIADIAZINE DERIVATIVES, METHOD FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2010-01-14 | — | — | WO | disclosed |
| US-20090275581-A1 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. | 2009-11-05 | — | — | US | disclosed |
| US-20090275581-A1 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. | 2009-11-05 | — | — | US | disclosed |
| US-20090275581-A1 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. | 2009-11-05 | — | — | US | disclosed |
| US-20090264428-A1 | Renin Inhibitors | VITAE PHARMACEUTICALS, INC. | 2009-10-22 | — | — | US | disclosed |
| US-20090264428-A1 | Renin Inhibitors | VITAE PHARMACEUTICALS, INC. | 2009-10-22 | — | — | US | disclosed |
| US-20090264428-A1 | Renin Inhibitors | VITAE PHARMACEUTICALS, INC. | 2009-10-22 | — | — | US | disclosed |
| US-20090233911-A2 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | NV REMYND (BE) | 2009-09-17 | — | — | US | disclosed |
| US-20090221822-A1 | Process for the Preparation of Dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2009-09-03 | — | — | US | disclosed |
| US-20090221822-A1 | Process for the Preparation of Dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2009-09-03 | — | — | US | disclosed |
| US-20090221822-A1 | Process for the Preparation of Dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2009-09-03 | — | — | US | disclosed |
| US-7582760-B2 | 7-Chloro-1-(3-fluoro-benzyl)-4-piperazin-1-yl-1,3-dihydro-benzoimidazol-2-one; useful for modulating the 5-HT6 receptor; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy etc. | ROCHE PALO ALTO LLC (US) | 2009-09-01 | — | — | US | disclosed |
| US-7582760-B2 | 7-Chloro-1-(3-fluoro-benzyl)-4-piperazin-1-yl-1,3-dihydro-benzoimidazol-2-one; useful for modulating the 5-HT6 receptor; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy etc. | ROCHE PALO ALTO LLC (US) | 2009-09-01 | — | — | US | disclosed |
| US-7582760-B2 | 7-Chloro-1-(3-fluoro-benzyl)-4-piperazin-1-yl-1,3-dihydro-benzoimidazol-2-one; useful for modulating the 5-HT6 receptor; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy etc. | ROCHE PALO ALTO LLC (US) | 2009-09-01 | — | — | US | disclosed |
| EP-1685123-B1 | SUBSTITUTED DIHYDROQUINAZOLINES II | BAYER HEALTHCARE AG (DE) | 2009-08-19 | — | — | EP | disclosed |
| EP-1685123-B1 | SUBSTITUTED DIHYDROQUINAZOLINES II | BAYER HEALTHCARE AG (DE) | 2009-08-19 | — | — | EP | disclosed |
| CN-100503577-C | Disubstituted pyrazolyl carboxanilides | BAYER CROPSCIENCE AG (DE) | 2009-06-24 | — | — | CN | disclosed |
| US-20090118305-A1 | PYRIDINE AND PYRAZINE DERIVATIVES - 083 | ASTRAZENECA AB (SE) | 2009-05-07 | — | — | US | disclosed |
| WO-2009053737-A2 | PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS | ASTRAZENECA AB (SE) | 2009-04-30 | — | — | WO | disclosed |
| US-7521397-B2 | Disubstituted pyrazolyl carboxanilides | BAYER CROPSCIENCE AG (DE) | 2009-04-21 | — | — | US | disclosed |
| US-20090081158-A1 | PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV | IDENIX PHARMACEUTICALS, INC. (US) | 2009-03-26 | — | — | US | disclosed |
| WO-2009032180-A1 | PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV | IDENIX PHARMACEUTICALS, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| US-7501512-B2 | Chemical compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-03-10 | — | — | US | disclosed |
| US-20090054410-A1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | NV REMYND (BE) | 2009-02-26 | — | — | US | disclosed |
| EP-2010488-A2 | RENIN INHIBITORS | Vitae Pharmaceuticals, Inc. (US) | 2009-01-07 | — | — | EP | disclosed |
| EP-1654232-A4 | SULFONYL SUBSTITUTED N-(BIARYLMETHYL) AMINOCYCLOPROPANECARBOXAMIDES | MERCK & CO INC (US) | 2008-11-12 | — | — | EP | disclosed |
| CN-101263136-A | Benzimidazole derivatives as 5-HT6, 5-HT24 | HOFFMANN LA ROCHE (CH) | 2008-09-10 | — | — | CN | disclosed |
| CN-101213180-A | Process for preparing dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2008-07-02 | — | — | CN | disclosed |
| CN-100393706-C | Substituted dihydrochinazolines having antiviral properties | BAYER HEALTHCARE AG (DE) | 2008-06-11 | — | — | CN | disclosed |
| EP-1904483-A1 | BENZIMIDAZOLE DERIVATIVES AS 5-HT6,5-HT24 | F. Hoffmann-Roche AG (CH) | 2008-04-02 | — | — | EP | disclosed |
| EP-1893587-A1 | METHOD FOR PRODUCING DIHYDROQUINAZOLINES | Bayer HealthCare AG (DE) | 2008-03-05 | — | — | EP | disclosed |
| EP-1625129-B1 | HETEROCYCLYL-SUBSTITUTED DIHYDROQUINAZOLINES AND USE THEREOF AS AN ANTIVIRAL AGENT | BAYER HEALTHCARE AG (DE) | 2008-03-05 | — | — | EP | disclosed |
| EP-1625129-B1 | HETEROCYCLYL-SUBSTITUTED DIHYDROQUINAZOLINES AND USE THEREOF AS AN ANTIVIRAL AGENT | BAYER HEALTHCARE AG (DE) | 2008-03-05 | — | — | EP | disclosed |
| US-7332499-B2 | Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides | MERCK & CO., INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-7329633-B2 | Disubstituted pyrazolylcarboxanilides | BAYER CROPSCIENCE AG (DE) | 2008-02-12 | — | — | US | disclosed |
| US-20080015244-A1 | Disubstituted pyrazolyl carboxanilides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2008-01-17 | — | — | US | disclosed |
| US-20070281953-A1 | Substituted Dihydroquinazolines II | BAYER HEALTHCARE AG (DE) | 2007-12-06 | — | — | US | disclosed |
| US-20070281953-A1 | Substituted Dihydroquinazolines II | BAYER HEALTHCARE AG (DE) | 2007-12-06 | — | — | US | disclosed |
| US-20070281953-A1 | Substituted Dihydroquinazolines II | BAYER HEALTHCARE AG (DE) | 2007-12-06 | — | — | US | disclosed |
| WO-2007117482-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007117482-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007117559-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007117559-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| US-20070191387-A1 | Substituted dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20070191387-A1 | Substituted dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20070191387-A1 | Substituted dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20070185121-A1 | Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents | BAYER HEALTHCARE AG (DE) | 2007-08-09 | — | — | US | disclosed |
| US-20070185121-A1 | Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents | BAYER HEALTHCARE AG (DE) | 2007-08-09 | — | — | US | disclosed |
| US-20070185121-A1 | Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents | BAYER HEALTHCARE AG (DE) | 2007-08-09 | — | — | US | disclosed |
| US-7196086-B2 | Substituted dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2007-03-27 | — | — | US | disclosed |
| US-7196086-B2 | Substituted dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2007-03-27 | — | — | US | disclosed |
| US-7196086-B2 | Substituted dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2007-03-27 | — | — | US | disclosed |
| US-20070049577-A1 | CGRP antagonists | BRISTOL-MYERS SQUIBB COMPANY | 2007-03-01 | — | — | US | disclosed |
| EP-1622880-B1 | SUBSTITUTED DIHYDROCHINAZOLINES HAVING ANTIVIRAL PROPERTIES | BAYER HEALTHCARE AG (DE) | 2007-02-28 | — | — | EP | disclosed |
| EP-1622880-B1 | SUBSTITUTED DIHYDROCHINAZOLINES HAVING ANTIVIRAL PROPERTIES | BAYER HEALTHCARE AG (DE) | 2007-02-28 | — | — | EP | disclosed |
| WO-2007006677-A1 | BENZIMIDAZOLE DERIVATIVES AS 5-HT6,5-HT24 | F. HOFFMANN-LA ROCHE AG (CH) | 2007-01-18 | — | — | WO | disclosed |
| WO-2007006677-A1 | BENZIMIDAZOLE DERIVATIVES AS 5-HT6,5-HT24 | F. HOFFMANN-LA ROCHE AG (CH) | 2007-01-18 | — | — | WO | disclosed |
| US-20070015744-A1 | Benzimidazolone and dihydroindolone derivatives and uses thereof | ROCHE PALO ALTO LLC | 2007-01-18 | — | — | US | disclosed |
| US-20070015744-A1 | Benzimidazolone and dihydroindolone derivatives and uses thereof | ROCHE PALO ALTO LLC | 2007-01-18 | — | — | US | disclosed |
| US-20070015744-A1 | Benzimidazolone and dihydroindolone derivatives and uses thereof | ROCHE PALO ALTO LLC | 2007-01-18 | — | — | US | disclosed |
| WO-2006133822-A1 | METHOD FOR PRODUCING DIHYDROQUINAZOLINES | BAYER HEALTHCARE AG (DE) | 2006-12-21 | — | — | WO | disclosed |
| EP-1730137-A1 | HETEROCYCLIC CGRP ANTAGONISTS FOR THE TREATMENT OF MIGRAINE | Bristol-Myers Squibb Company (US) | 2006-12-13 | — | — | EP | disclosed |
| US-20060247229-A1 | Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides | MERCK SHARP & DOHME CORP. | 2006-11-02 | — | — | US | disclosed |
| US-20060235032-A1 | Substituted quinazolines as antiviral agents, especially against cytomegaloviruses | AIC246 AG & CO. KG (DE) | 2006-10-19 | — | — | US | disclosed |
| CN-1832922-A | Sulfonyl-substituted N- (biarylmethyl) aminocyclopropanecarboxamides | MERCK & CO INC (US) | 2006-09-13 | — | — | CN | disclosed |
| US-20060178384-A1 | 2-(2,6-dimethoxy-phenylamino)-9-methoxy-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one; 3-bromo-N-[3-(9-methoxy-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-ylamino)-phenyl]-benzamide; kinase inhibitor; neutropenia; cytopenia; anemias | SMITHKLINE BEECHAM CORPORATION | 2006-08-10 | — | — | US | disclosed |
| EP-1685123-A2 | SUBSTITUTED DIHYDROQUINAZOLINES II | Bayer HealthCare AG (DE) | 2006-08-02 | — | — | EP | disclosed |
| CN-1784390-A | Substituted dihydrochinazolines having antiviral properties | BAYER HEALTHCARE AG (DE) | 2006-06-07 | — | — | CN | disclosed |
| US-20060116414-A1 | Disubstituted pyrazolyl carboxanilides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2006-06-01 | — | — | US | disclosed |
| CN-1780622-A | 4-(2-phenylsulfanyl-phenyl)-piperidine derivates as serotonin reuptake inhibitors | LUNDBECK & CO AS H (DK) | 2006-05-31 | — | — | CN | disclosed |
| US-20060100242-A1 | such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders | H.LUNDBECK A/S (DK) | 2006-05-11 | — | — | US | disclosed |
| EP-1654232-A1 | SULFONYL SUBSTITUTED N-(BIARYLMETHYL) AMINOCYCLOPROPANECARBOXAMIDES | Merck & Co., Inc. (a New Jersey corp.) (US) | 2006-05-10 | — | — | EP | disclosed |
| WO-2006040646-A1 | BENZIMIDAZOLE OR INDOLE AMIDES AS INHIBITORS OF PIN1 | PFIZER, INC. (US) | 2006-04-20 | — | — | WO | disclosed |
| EP-1641766-A2 | NOVEL CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-04-05 | — | — | EP | disclosed |
| EP-1626720-A1 | 4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H. Lundbeck A/S (DK) | 2006-02-22 | — | — | EP | disclosed |
| EP-1625129-A1 | HETEROCYCLYL-SUBSTITUTED DIHYDROQUINAZOLINES AND USE THEREOF AS AN ANTIVIRAL AGENT | Bayer HealthCare AG (DE) | 2006-02-15 | — | — | EP | disclosed |
| EP-1622880-A1 | SUBSTITUTED DIHYDROCHINAZOLINES HAVING ANTIVIRAL PROPERTIES | Bayer HealthCare AG (DE) | 2006-02-08 | — | — | EP | disclosed |
| WO-2005095383-A1 | HETEROCYCLIC CGRP ANTAGONISTS FOR THE TREATMENT OF MIGRAINE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-10-13 | — | — | WO | disclosed |
| US-20050215576-A1 | Novel therapeutic agents for the treatment of migraine | BRISTOL-MYERS SQUIBB COMPANY | 2005-09-29 | — | — | US | disclosed |
| EP-1562913-A1 | SUBSTITUTED QUINAZOLINES AS ANTIVIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALOVIRUSES | Bayer HealthCare AG (DE) | 2005-08-17 | — | — | EP | disclosed |
| CN-1646494-A | Disubstituted pyrazolyl carboxanilides | BAYER CROPSCIENCE AG (DE) | 2005-07-27 | — | — | CN | disclosed |
| WO-2005047278-A2 | SUBSTITUTED DIHYDROQUINAZOLINES II | BAYER HEALTHCARE AG (DE) | 2005-05-26 | — | — | WO | disclosed |
| US-20050065160-A1 | Substituted dihydroquinazolines | BAYER HEALTHCARE AG (DE) | 2005-03-24 | — | — | US | disclosed |
| WO-2005016886-A1 | SULFONYL SUBSTITUTED N-(BIARYLMETHYL) AMINOCYCLOPROPANECARBOXAMIDES | MERCK & CO., INC. (US) | 2005-02-24 | — | — | WO | disclosed |
| WO-2005007092-A2 | NOVEL CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-01-27 | — | — | WO | disclosed |
| EP-1490342-A1 | DISUBSTITUTED PYRAZOLYL CARBOXANILIDES | Bayer CropScience AG (DE) | 2004-12-29 | — | — | EP | disclosed |
| WO-2004099212-A1 | HETEROCYCLYL-SUBSTITUTED DIHYDROQUINAZOLINES AND USE THEREOF AS AN ANTIVIRAL AGENT | BAYER HEALTHCARE AG (DE) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004096778-A1 | SUBSTITUTED DIHYDROCHINAZOLINES HAVING ANTIVIRAL PROPERTIES | BAYER HEALTHCARE AG (DE) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004087156-A1 | 4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H. LUNDBECK A/S (DK) | 2004-10-14 | — | — | WO | disclosed |
| US-6774132-B1 | Spirooxindole derivatives that act as analgesics | ASTRAZENECA AB (SE) | 2004-08-10 | — | — | US | disclosed |
| EP-1426375-A2 | Analgesic spiroindole derivatives | AstraZeneca AB (SE) | 2004-06-09 | — | — | EP | disclosed |
| WO-2004041790-A1 | SUBSTITUTED QUINAZOLINES AS ANTIVIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALOVIRUSES | BAYER HEALTHCARE AG (DE) | 2004-05-21 | — | — | WO | disclosed |
| US-20040087800-A1 | Spirooxindole derivatives are analgesics for the treatment of chronic pain. | ASTRAZENECA AB | 2004-05-06 | — | — | US | disclosed |
| EP-1202994-B1 | NEW COMPOUNDS | ASTRAZENECA AB (SE) | 2004-04-14 | — | — | EP | disclosed |
| WO-2003070705-A1 | DISUBSTITUTED PYRAZOLYL CARBOXANILIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2003-08-28 | — | — | WO | disclosed |
| CN-1361779-A | Novel compounds | ASTRAZENECA AB (SE) | 2002-07-31 | — | — | CN | disclosed |
| EP-1202994-A1 | NEW COMPOUNDS | AstraZeneca AB (SE) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001005790-A1 | NEW COMPOUNDS | ASTRAZENECA AB (SE) | 2001-01-25 | — | — | WO | disclosed |
| EP-0518374-B1 | A process for the preparation of alkyl 3-chloroanthranilates | DOWELANCO (US) | 1996-05-01 | — | — | EP | disclosed |
| EP-0178581-B1 | Use of 2-[(2-bromo-6-fluorophenyl)imino]imidazolidine as a sedative | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 1992-01-22 | — | — | EP | disclosed |
| US-4624960-A | 2-112-BROMO-6-FLUOROPHENYLIMINOIMIDAZOLIDINE | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 1986-11-25 | — | — | US | disclosed |
| EP-0178581-A2 | Use of 2-[(2-bromo-6-fluorophenyl)imino]imidazolidine as a sedative | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 1986-04-23 | — | — | EP | disclosed |
| US-4518799-A | GRIGNARD REAGENTS AND THEIR PREPARATION | THE UPJOHN COMPANY (US) | 1985-05-21 | — | — | US | disclosed |
| US-4443631-A | DIMETHYLFORMAMIDE OR DIMETHYLACETAMIDE SOLVENT 2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID INTERMEDIATE | THE UPJOHN COMPANY (US) | 1984-04-17 | — | — | US | disclosed |
| US-4166859-A | 2-Bromo-6-fluoro-N-(2-imidazolidinylidene)-benzamine and salts thereof and the use to treat hypertension | BOEHRINGER INGELHEIM GMBH (DE) | 1979-09-04 | — | — | US | disclosed |
| US-4147804-A | ANTIARRHYTHMIA AGENTS | WILLIAM H. RORER, INC. (US) | 1979-04-03 | — | — | US | disclosed |
| US-4147804-A | ANTIARRHYTHMIA AGENTS | WILLIAM H. RORER, INC. (US) | 1979-04-03 | — | — | US | disclosed |